Latest posts
-
Coal India, NTPC among 360 ONE Capital Research’s 8 stock picks for October. Check full list with target prices
360 ONE Capital Research has picked eight stocks for October, including Coal India, NTPC and ITC, with Buy ratings and target prices, citing earnings prospects and growth drivers.Coal India, NTPC among 360 ONE Capital Research’s 8 stock picks for October. Check full list with target prices
-
Can Parag Milk Foods Reach ₹10,000 Cr Revenue in the Next 3–4 Years?
This Small-Cap Stock, engaged in processing, manufacturing, marketing, and distributing milk, dairy products, cheese, paneer, ghee, whey protein, and other value-added dairy products, is in focus after the company announced an ambitious growth plan targeting Rs. 10,000 crore in revenue over the next three to four years, supported by capacity expansion and strong growth in…
-
DA news: Telangana Cabinet approves release of two pending instalments — when will remaining arrears be cleared?
The Telangana Cabinet has approved the release of two pending DA instalments for employees and pensioners, adding ₹2,500 crore annually to the state’s financial burden. Details here.
-
Bajaj Finance to raise Rs 17,500 cr via QIP, pref issue
Bajaj Finance plans to raise up to Rs 17,500 crore through a Rs 11,700-crore QIP and Rs 5,800 crore warrant issue to promoter Bajaj Finserv. The fundraising requires shareholder approval; institutional investors will receive QIP shares while promoter warrants could help maintain Bajaj Finserv’s stake and limit dilution.
-
Market crash wipes out Rs 26 lakh cr in 8 weeks! Why soaring bond yields may hurt Sensex, Nifty more than elevated oil prices
The Sensex and Nifty have fallen for eight straight weeks, wiping out more than Rs 26 lakh crore in market capitalisation. While elevated oil prices have pressured equities, soaring bond yields, foreign outflows, a stronger dollar and tighter liquidity are adding to the selling pressure and weighing on investor sentiment.
-
Pharma Stock With Revenue Growth Guidance of Up to 40% in FY27 to Add to Your Watchlist
The Indian pharmaceutical industry is seeing growing opportunities in generic medicines, supported by increasing demand across regulated and emerging markets. For pharma companies, product approvals, manufacturing capacity and faster commercialisation are becoming key drivers of revenue growth. With a market capitalisation of Rs. 6,211 cr, the shares of Senores Pharmaceuticals Ltd closed at Rs. 1348.75…
-
Jefferies is bullish on 6 healthcare stocks with upside potential of up to 46%. Own any?
Hospital stocks extended losses amid regulatory scrutiny over cancer-drug markups and pharmacy practices. Despite the selloff, Jefferies maintained Buy ratings on six healthcare companies, citing target-price upside ranging from 22% to 46% and strong projected EBITDA growth through FY29.
-
EPFO enrolment campaign for workers left out of PF coverage: Will they lose interest on past contributions?
Eligible salaried workers outside the formal provident fund system can be enrolled now through EPFO’s special one-time window. But does it mean they will lose interest on past contributions?
-
Club ITC Hotels Offers Up to 50,000 Green Points: HDFC Diners Black, Regalia Gold & SBI MILES Can Help You Earn More
Club ITC members can currently earn up to 50,000 bonus Green Points by completing eligible stays across participating ITC Hotels and other participating brands during the offer period. Separately, eligible HDFC Bank and SBI Card customers can transfer their credit-card reward currencies to Club ITC Green Points, making these cards relevant for customers who regularly…
-
Can Epigral’s Specialty Chemical Expansion Drive Revenue Mix to 70% by FY28?
The shares of this small cap company majorly engaged in the business of manufacturing chemicals which includes derivatives, speciality chemicals, and many more were in focus after the management targets 70% speciality chemicals revenue target. With the market capitalization of Rs. 4,273 Crores, the shares of Epigral Ltd were trading at around Rs.991 per share…